Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.279.60 CHF
Change Today +2.90 / 1.05%
Volume 1.3M
As of 11:43 AM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Severin Schwan Ph.D.

Chief Executive Officer and Director, Roche Holding AG
AgeTotal Calculated CompensationThis person is connected to 48 board members in 6 different organizations across 13 different industries.

See Board Relationships
48SFr.11,949,634
As of Fiscal Year 2014

Background*

Dr. Severin Schwan, Ph.D. has been Chief Executive Officer of Roche Holding AG since March 2008. Dr. Schwan has been Group Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2008. He served as the Chief Executive Officer of Roche Diagnostics Corporation since January 1, 2006. He served as Chief Executive Officer of Diagnostics Division at Roche Holding AG since January 2006. He served as Trainee of Corporate Finance at Roche Basel from 1993 to ...

Read Full Background

Corporate Headquarters*

Konzern-Hauptsitz
Basel, Basel-Stadt 4070

Switzerland

Phone: 41 61 688 11 11
Fax: 41 61 691 93 91

Board Members Memberships*

Chairman
2008-Present
Chairman of the Board
2013-Present
Chief Executive Officer and Director
2014-Present
Director and Member of Risk Committee
2014-Present
Director and Member of Risk Committee
2014-Present
Director and Member of Risk Committee

Education*

Unknown/Other Education
University of Oxford
Unknown/Other Education 1991
Universität Innsbruck
LLB 1991
Universität Innsbruck
Unknown/Other Education
University of York
Doctorate 1993
Universite catholique de Louvain

Other Affiliations*

Annual Compensation*

SalarySFr.4,000,000
BonusSFr.1,340,136
Total Annual CompensationSFr.5,340,136

Stock Options*

Restricted Stock AwardsSFr.6,056,252
All Other CompensationSFr.553,246
Total Value of OptionsSFr.22,155,938
Total Number of Options289,794

Total Compensation*

Total Annual Cash CompensationSFr.5,893,382
Total Short Term CompensationSFr.5,340,136
Other Long Term CompensationSFr.6,609,498
Total Calculated CompensationSFr.11,949,634
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROG:VX SFr.279.60 CHF +2.90

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$500.0K
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Jeffrey R. Immelt Executive Chairman and Chief Executive Officer
General Electric Company
$9.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROCHE HOLDING AG-GENUSSCHEIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.